SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDairy Crest Regulatory News (DCG)

  • There is currently no data for DCG

Interim Management Statement

5 Feb 2015 07:00

RNS Number : 0890E
Dairy Crest Group PLC
05 February 2015
 



 

5 February 2015

 

Dairy Crest Group plc ("Dairy Crest")

Interim Management Statement

 

Dairy Crest is today issuing its Interim Management Statement for the nine months ended 31 December 2014. Our Cheese and Spreads businesses have performed robustly in a widely- reported difficult environment. Against this background our Dairies business has continued to make losses.

 

We are pleased with the performance of our four key brands. Taken together, sales of Cathedral City, Country Life, Clover and FRijj have been flat over the nine month period compared to last year. Cathedral City, significantly the UK's leading cheddar brand, has continued to grow its market share and FRijj has performed strongly. However their growth has been offset by lower Clover and Country Life sales.

 

Sale of Dairies operations

 

On 6 November 2014 Dairy Crest announced that it had agreed to sell the assets of its Dairies operations to Müller UK & Ireland Group ("Müller"). The transaction is on track and has received the approval of Dairy Crest shareholders. It remains conditional on the approval of the relevant competition authorities. Dairy Crest and Müller have asked for the transaction to be referred back to the UK for review by the Competition and Markets Authority ("CMA") and are engaged in constructive talks with the European Commission and the CMA on this application with a view to progressing the merger review as quickly as possible.

 

Dairies performance

 

We continue to expect the second half performance of our Dairies business to be better than the first half. Milk costs have fallen but production is higher and selling prices are lower. This has adversely affected profits in this product group. We expect some of the shortfall to be offset by higher property profits, which we now expect to exceed those of the first half.

 

Cheese and Spreads

 

The third quarter performance of our Cheese and Spreads businesses, which will be the heart of Dairy Crest after the sale of our Dairies operations, has been more robust than that of Dairies. Lower cream prices have benefitted Spreads profits. However reduced whey realisations in particular and some reduced selling prices on the back of lower input costs have adversely affected Cheese profits. Taken together, trading in these businesses was in line with our expectations despite the challenging environment.

 

We have made good progress with the major projects that will grow future profits in these businesses. During the third quarter we transferred production to Kirkby and closed our Spreads manufacturing plant at Crudgington. Our innovation team, previously based at Crudgington, has moved to Harper Adams University where we are building a new innovation centre. Our demineralised whey and galacto-oligosaccharide projects at Davidstow which target the growing, global infant formula market, remain on budget and we expect to start manufacturing both products towards the end of this summer.

 

We continue to anticipate that year end net debt will be significantly lower than at 30 September 2014.

 

Board change

 

On 31 March 2015, Martyn Wilks, Executive Managing Director, will leave Dairy Crest to pursue other interests. Martyn has been on the Board for over seven years and has played a key role in building our brands, by increasing our focus on the consumer and developing our innovation capability. At this time he will not be replaced on the Board. Most of his key responsibilities will transfer to Adam Braithwaite. Adam has held the role of Group Commercial Director for the past two years and was appointed to the Management Board earlier this year. He has worked for Dairy Crest for over 13 years in a number of senior customer-facing roles.

 

 

Mark Allen, Chief Executive of Dairy Crest, commented:

 

"Against the background that we operate in, Dairy Crest has delivered a solid performance. Maintaining the sales of our four key brands in line with last year and growing our overall Cheese and Spreads profits is a good result in today's challenging environment. We continue to strengthen these businesses and are investing for future growth."

 

"The performance of our Dairies business reflects the difficulties facing the whole UK dairy sector. The proposed sale of our Dairies operations, which is progressing to plan, will lead to economies of scale. These are necessary to underpin the value currently being offered to consumers and to help the UK dairy sector compete in global markets".

 

"I would like to take this opportunity to thank Martyn Wilks for his important contribution to the business over the last seven years. He has made a significant difference to the performance of our brands in that time and leaves with our best wishes for the future."

 

 

Dairy Crest will issue its Preliminary Results for the year ending 31 March 2015 on 21 May 2015.

 

 

For further information, please contact:

 

Dairy Crest Group plc

Arthur Reeves

 

01372 472236

 

Brunswick

Tim Danaher

 

020 7404 5959

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSDZLFBELFZBBX
Date   Source Headline
22nd Feb 20192:11 pmRNSForm 8.3 - Dairy Crest Group plc
22nd Feb 201911:51 amGNWDimensional Fund Advisors Ltd. : Form 8.3 - [Insert name of offeree or offeror]
22nd Feb 201911:10 amPRNForm 8 (OPD) - Dairy Crest Group Plc
22nd Feb 201910:40 amRNSForm 8.3 - Dairy Crest Group Plc
22nd Feb 20197:14 amRNSRecommended Cash Acquisition of Dairy Crest plc
5th Feb 201910:25 amRNSPCA Dealing
1st Feb 20192:43 pmRNSDirector/PDMR Shareholding
31st Jan 20199:58 amRNSTotal Voting Rights
31st Jan 20197:00 amRNSTrading Statement
7th Jan 20193:44 pmRNSDirector / PDMR Shareholding
2nd Jan 20199:47 amRNSTotal Voting Rights
30th Nov 201811:01 amRNSTotal Voting Rights & Capital
7th Nov 20189:09 amRNSCorrection: Interim results
7th Nov 20187:00 amRNSInterim Results
2nd Nov 201811:21 amRNSNotification of Major Holdings
2nd Nov 201811:20 amRNSNotification of Major Holdings
31st Oct 201810:37 amRNSTotal Voting Rights & Capital
17th Oct 20183:35 pmRNSStandard form for notification of major holdings
11th Oct 20182:20 pmRNSStandard form for notification of major holdings
28th Sep 201812:34 pmRNSTotal Voting Rights & Capital
18th Sep 201810:27 amRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSTrading Update
31st Aug 20187:00 amRNSTotal Voting Rights & Capital
20th Aug 20183:26 pmRNSDirector/PDMR Shareholding
13th Aug 20185:15 pmRNSDirector / PDMR Shareholding
6th Aug 20184:43 pmRNSDirector / PDMR Shareholding
31st Jul 201812:04 pmRNSTotal Voting Rights & Capital
18th Jul 20189:54 amRNSResult of AGM
17th Jul 20187:00 amRNSAGM and Trading Update
12th Jul 201811:54 amRNSBlock listing application
6th Jul 20185:01 pmRNSDirector/PDMR Shareholding
29th Jun 201812:56 pmRNSTotal Voting Rights & Capital
28th Jun 201810:18 amRNSDirector Dealing
21st Jun 201810:09 amRNSDirector and PCA Dealing
20th Jun 20182:05 pmRNSBlock listing Interim Review
19th Jun 201811:57 amRNSTR-1: Notification of major holdings
15th Jun 20185:30 pmRNS2018 Annual Report and Accounts and Notice of AGM
8th Jun 201812:39 pmRNSDirector and PCA Dealing
1st Jun 20189:49 amRNSTotal Voting Rights & Capital
31st May 201810:38 amRNSDirector / PDMR Shareholding
23rd May 201810:01 amRNSRESULT OF PLACING OF NEW ORDINARY SHARES
23rd May 20187:01 amRNSPROPOSED PLACING OF NEW ORDINARY SHARES
23rd May 20187:00 amRNSPreliminary Results
10th May 20184:08 pmRNSBlock Listing Application
10th May 20182:33 pmRNSNon-executive Director Appointment
30th Apr 20181:47 pmRNSTotal Voting Rights & Capital
29th Mar 20182:09 pmRNSTotal Voting Rights & Capital
28th Feb 201811:19 amRNSTotal Voting Rights & Capital
16th Feb 20185:10 pmRNSDirector/PDMR Shareholding
9th Feb 201812:24 pmRNSNotification of Major Holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.